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"~ Factors  the Non-Administrat ion of  Influencing 
Thrombolyt l¢  Therapy In 17944 Patients 
Randomized to GISSI-3 Trial 
Aldo P. Meggiont, Marco Bobbio, Robsrto Malacdda, MadaGrazia Frenzoal, 
Slmona Badara, Gianni Tegnoni, on behalf of the GISSI-3 Investigators. 
GISSI-3 Coordinating Centre, ANMCO and M. Negri Institute, italy 
To evaluate the effect of these data on clinical practice, we evaluated the 
impact on "IT administration in the pts randomized in GISSI-3 trial in 1991- 
1993 by 200 Italian CCUs, representing about the 80% of the existing COL.Is 
in the COUnTy at that time. GISSI-3 trial allowed to observe practice pat- 
tsms on 1"1", because decisions about all treatments except nitrates and 
ACE-fnhlbitora were left to the responsible physician. 12918 (72%) of the 
17944 pts with confirmed MI randomized in the study received TT. Strep- 
tokinase was utilized in 43.4% of TT pts, tPA in 40,9%, urokinase in 9.2°/o 
and APSAC in 5,8%. The relationship between clinical-epidemiolnglcal vad- 
abtes and TT non-utilization was evaluated by multiple logistic regression. 
The following factors were independently associated with non-administration 
of TT: 
Factor % utilization OR 95% CI 
"lime from symptom onset 
13-24 24.1 13.98 12.28-15.92 
7-12 50.5 4.01 3.64-4.43 
ST depression at entry 49,3 3.28 2,81-3.83 
Age (>70 years) 56.5 2.59 2.38-2.81 
Previeu8 AM! 67.5 1.39 1.25-1.54 
Hospital W'dlLout Cath Lab ± Cardiac Surgery 
70.0 1.28 1.18-1.39 
Gender (female) 63,7 1.20 1.10-1.31 
A late hospital admission and ST depression at entry resulted as the 
strongest predictors for TT non-administration. However, TT utilization was 
unexpectedly high also in the tots with these characteristics, in which no 
evidence of benefit from TT is available. 
~-~ Operator Reported Success of Percutaneous 
Coronary Revascularlzatlon Predlcte Patient 
Reported Phy=lcal Functioning at 6 Months 
Ira S. Nesh0 Lestey Curtis, Jennifer Becker, Haya Rubin. Mount Sinai 
School of Medicine, New York, NY; The Academic Medical Center 
Consortium, Rochester, NY 
Percutaneeus coronary revasculadzation (PCR) improves survival onl,, in 
highly select groups, though it may improve quality of life. Patient reported 
physical functioning (PF) POst-PCR is therefore of interest, but, unlike oper- 
ator reported procedural success (PS), is not routinely assessed. We sought 
to determine whether PS predicted patient reported physical functioning (PF) 
on the SF-36 at 6 months post-PCR. We developed a multivariate model 
to predict late PF in poti:nts undergoing PCR at 12 Academin Medical 
Center Consortium member institutions, based on pre-PCR $F-30 scores, 
the severity of ischemic disease and non-ischemio comorbldities. Complete 
pro- and post-PCR PF data were available for 740 patients, 6.3°/= of the 
consortium cases over the same time. Without including PS, independent 
predictors (each p < 0.05) of PF were: baseline PF, health perception and 
social functioning scores° composite comofoldity index, hematocfit and CHR 
PS, defined as • 2(P/o reduction of stenoals with < 500/° residual without 
major complication was added as a dichotomous vadable by grouping partial 
and complete sucoe~s. 709 PCR's were successful (96%). Success was an 
independent predictor (p < 0.05) of an increase of 7.7 :J: 3.9 on the 100 point 
PF scale at 6 months past-PCR. In the ~sence of available patient reported 
post-PCR PF, operator reported PS remains an important measure of the 
overal; utility of PCR. 
Risk of Death While Waiting for Coronary ByPass 
Surgery and Its Relstionshlp to Health Insurance 
Sigmund Silbsr, Holger M0hllng, RCIf DOff, Gunnar Zlndler, Uwe K0nig, 
Anne PrsuS, Andrea StOmpfL Dr. MOiler Hospital, Munich, Germany 
In Germany, there are still waiting lists for CABG surgery: the risk involved in 
waiting Is controversial. We therefore conducted a prospective study in over 
1000 consecutive patients randomly referred to vadous surgical departments 
In Bavaria and Switzerland. Results: Separation from families: 84°/= of the 
urgent cases with social health Insurance (SOCL) had to leave Munich, 
while only 250/0 pdvatsly insured (PRIV) pats were separated from their 
environment. 79% of the elective cases with SOCL and 92% with PRIV were 
operated in Munich. Waiting times: All emergency cases could be operated 
the same day. For pats classified as urgent, the average waiting time was 
9 days independent of the type of health insurance. In contrast, SOCL pats 
classified as "elective" had to wait the double amount of time (60 days) 
compared wth PRIV pats (30 days). The risk of death while waiting for 
CABG was 1% per month for'elective" cases. 
Conclusions: Pats with $OCL insurance needing urgent CABG are sepa- 
rated from their families 4.5 times more than PRIV pats. The risk of dying on 
the waiting list was 1% per month. Since "elective" SOCL pats walt longer 
than PRIV pats, their risk of death on the waiting list is higher. 
~ Immediste Irnprassion of the L, illty of 
"rmnmmophogenl Echo Is Confirmed at Follow-up: 
V.O.T.E. II Study 
Ravin Davldoff, Abbss Gol:al, Heather Rorescue, Michael Pisard, 
Stevan Goldstaln, Steven Schwartz, Michael Motto, Zvi Vared, 
Daniel Bicardo, itzhak Kronzon, Shunfchi Homma, MaryAnn McLaughltn, 
Lee Goldman, Martin E. Goldman. Mount Sinai Medical Center, New York, 
NY 
Vadous methods are utilized to determine the value of medical technology 
on clinical care. _The Value Of T_ransesophageel Echo (V.O.T.E.) I Study had 
reported an immediate impact on clinical management (MNG&) in 36.2% of 
the first 4600 10ts recruited, However, labodous reboepectlve chart review 
to determine whether the initial M.D. impression was confirmed by subse- 
quent clinical course was not feasible in a study this size, Thus V.O.T.E. 
II incorporated an expanded baseline physician questionnaire and a _> 1 
week follow-up (F/U) form when the referring physician was asked about the 
pts' subsequent clinical course. Specifically, whether other studias confirmed 
TEE findings or if the clinical outcome differed (Diff) from that expected from 
the TEE results, The VOTE II pilot study has enrolled 1255 pts. The largest di- 
agnostic groups included evaluation of stroke related (CVA/TIA), endocarditis 
(Endo), native (Nat) or prosthetic (Prosth) valves (V) and LV function (Fx). 
VOTE I% VOTE I1% MNGA F/U Oiff 
CV/VTIA 26.8 21.8 26,4 6.0 
Endo 16.9 "~7.9 33.8 10 
Native V 15.9 12.7 39.4 0,6 
Pmsth V 8.9 6.5 21 5.0 
LV Fx 3,2 6.8 30.6 2,3 
TOTAL 4600 pts 1255 pls 33.1% 5.1% 
In the first 1255 pl3 recruited, follow-up indicated a different clinical course 
than expected from the TEE in only 5.1% of applicable pte. Additionally, TEE 
eliminated other procedures in 10.2% of pts and was confirmed hy other 
studies in 35.9%. The immediate complication rate was 1.0%, however an 
adverse reaction was reported in 2.2% of pts at F/U. Thus the V.O.T.E. II pilot 
study • 1 week follow-up confirms that physicians' immediate integration e,"~:l 
utilization of TEE results is confirmed by the patients' clinical course. 
Computer Applications in Cardiovascular 
Disease 
Tuesday, March 26, 1996, Noon--2:00 p.m. 
Orange County Convention Center, Hall E 
Presentation Hour: 1:00 p.m.-2:00 p.m. 
~ 1  The Use of Neural Networks for Early Diagnosis 
-- and Exclusion of Acute Myocardial Infarction 
B. Undahl, J. Ellenlus, T. Groth, L. Wallentin. Dept. of Cardiology Unlversily 
Hospital of Uppsala and Unit for Biomedical Systems An~tysis, University of 
Uppsala, Sweden 
The aim of this study was to assess the ability of neural networks (NN) to 
eady verify/exclude AMI/and predict infarct size, and to compare the ability 
of NN with that of physicians. 
88 patients without ST-elevation or with contraindications against throm- 
bolysis and with onset of chest pain < 8 h were included. Blood samples 
for analyses of plasma CK-MB, myeglo~in ,~nd ~,'oponin T (Tn-T) were col- 
lected every 30 minutes during the first 3 h, then after 4, 6, 9, 12, 18, 24 
AMI non-AMI 
n - 11 MMD n = 8 non-MMD n = 19 
Phy.* NN Phy." NN Phy.* NN 
sens. 1 .O 1.0 0.28 0.62 0.98 1.0 
spec, 0.94 0.93 0.98 1 .O 0.78 0.95 
pos PV 0.88 0.85 0.88 1.0 0.82 0.95 
nag PV 0,88 0.85 0.88 1.0 0.82 0.95 
time.#" (rain) 35 10 565 180 148 180 
• Mean value of 1he three physicians; #time to diagnosis, 
